Personalized medicine 2016
Molecular diagnostics is considered a driving force behind growth, with annual growth rates above nine percent. How can diagnostics SMEs participate in this rapidly growing segment? The analytica theme day on personalized medicine on May 13, 2016 with some 500 visitors had the answer.
Determining the status quo of individual stratified treatment
Among other things, experts from pharmaceutical and diagnostics companies, trade associations and clusters reported on and discussed the following topics in lectures, business pitches and panel discussions:
- What has already been achieved in the sector for individual stratified treatment?
- Where are the new technologies reaching their limits?
- What successes can we already look back on?
- Is personalized medicine popular among patients? If not, is its development being slowed by regulatory issues, science or subsequent reimbursement problems?
Personalized medicine program 2016
Information about the lectures and speakers at the theme day on personalized medicine at analytica 2016 is available in our event database.